Alekseeva G G
Probl Endokrinol (Mosk). 1978 Jan-Feb;24(1):3-9.
The growth hormone and blood sugar level was determined during compensation in 38 insulin-resistant and in 48 insulin-sensitive patients with diabetes mellitus, on fasting stomach and after an intravenous injection of insulin. The insulin-resistant patients were given insulin in the amount of 100 and more Units per 24 hours at the period of achievement of compensation. In the insulin-sensitive patients with diabetes mellitus during the compensation the growth hormone level in the blood serum on fasting stomach displayed a significant reduction; no significant change occurred in the insulin-resistant patients. On the achievement of normoglycemia a high growth hormone level in the patients with insulin-resistant forms of diabetes mellitus was probably conditioned by disturbance of the adaptation processes, and possibly also by the preservation of decreased glucose metabolism at the cell level. Under these conditions the growth hormone apparently produced a diabetogenic action and prevented stable compensation creating conditions for the preservation of insulin resistance.
在38例胰岛素抵抗型和48例胰岛素敏感型糖尿病患者达到代偿期时,于空腹及静脉注射胰岛素后,测定其生长激素和血糖水平。在达到代偿期时,胰岛素抵抗型患者每24小时给予100单位及以上剂量的胰岛素。在胰岛素敏感型糖尿病患者达到代偿期时,空腹血清生长激素水平显著降低;而胰岛素抵抗型患者未出现显著变化。在胰岛素抵抗型糖尿病患者血糖恢复正常时,其生长激素水平较高,这可能是由于适应过程紊乱,也可能是由于细胞水平葡萄糖代谢降低的状况持续存在。在这些情况下,生长激素显然产生了致糖尿病作用,并阻碍了稳定代偿的实现,为胰岛素抵抗的持续存在创造了条件。